The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
BRM promoter insertion/deletion polymorphisms in hepatocellular carcinoma risk and survival.
Kit Man Wong
No relevant relationships to disclose
Geoffrey Liu
No relevant relationships to disclose
Jonghun John Lee
No relevant relationships to disclose
Osvaldo Espin-Garcia
No relevant relationships to disclose
Yonathan Brhane
No relevant relationships to disclose
Dangxiao Cheng
No relevant relationships to disclose
Zhuo Chen
No relevant relationships to disclose
Devalben Patel
No relevant relationships to disclose
Catherine Brown
No relevant relationships to disclose
Amy Wong
No relevant relationships to disclose
David Reisman
Employment or Leadership Position - Zenagene
Stock Ownership - Zenagene
Wei Xu
No relevant relationships to disclose
Jennifer J. Knox
No relevant relationships to disclose
Sean P. Cleary
No relevant relationships to disclose
Rayjean J Hung
No relevant relationships to disclose